Metformin with standard neoadjuvant chemotherapy in breast carcinoma
ConclusionMetformin has a significant antineoplastic effect which was measured in this study in terms of significant increase in pathological response concurrently with neoadjuvant chemotherapy in breast cancer compared to giving neoadjuvant chemotherapy alone.
Source: QJM - Category: Internal Medicine Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Diabetes | Docetaxel | Endocrinology | Fortamet | Herceptin | Internal Medicine | Metformin | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Oral Cancer | Study | Taxotere | Toxicology | Women